New Ultrasound System Facilitates Catheter and IV Placement
Offering a variety of integrated visualization tools, the SiteRite 9 Ultrasound System reportedly enables the insertion of vascular access devices regardless of user experience level.
For clinicians placing central venous catheters, peripherally inserted central catheters (PICCs) and IV lines, BD has launched the SiteRite™ 9 Ultrasound System.
In addition to a 15.6-inch touch screen with enhanced image quality, the SiteRite 9 Ultrasound System enables real-time needle monitoring with the Cue™ Needle Tracking System and guided catheter tip navigation with the Sherlock 3CG+™ Tip Confirmation System, according to BD.
The company added that the system also facilitates appropriate catheter selection with a combination of automated vessel assessment tools and vessel measurement capability.
"Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians — whether they've been on the job for years or are new to the field," said Eric Borin, the worldwide president of Medication Delivery Solutions at BD. " … We've developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved."
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
